Insulin Therapy Optimization

Introduction to Insulin Glargine

• The American Academy of Family Physicians and the American College of Physicians recommend using insulin glargine (Lantus) in combination with short-acting insulin analogues for meal coverage in patients with type 1 diabetes, and alongside oral hypoglycemic agents for patients with type 2 diabetes 1, 2

Dosing and Titration

• For patients requiring high insulin doses, twice-daily dosing may be more effective than once-daily dosing, with a total daily dose threshold of 0.5 units/kg/day indicating potential overbasalization and risk of hypoglycemia, as recommended by the American Academy of Family Physicians and the American Diabetes Association 1, 3, 4
• When transitioning from once-daily to twice-daily Lantus, the dose should be divided, typically distributing as 2/3 in the morning and 1/3 in the evening, and titrated based on pre-dinner and fasting morning glucose readings using an evidence-based titration algorithm, such as increasing by 2 units every 3 days until reaching target without hypoglycemia 1, 3, 4
• When switching from twice-daily Lantus to once-daily dosing, combine the total daily dose and administer 80% of this amount as a single daily dose, preferably at bedtime, to lower the risk of hypoglycemia, with a conversion factor represented in the following table:

3, 4

Special Considerations

• Insulin glargine should not be mixed with other insulins in the same syringe due to its acidic pH, as recommended by the American Diabetes Association and stated by 5, 1, 2

Common Pitfalls

• Underdosing, failure to recognize the need for split dosing, improper dose distribution, and inadequate monitoring can lead to suboptimal glycemic control and increased risk of hypoglycemia, and clinicians should be aware of these potential pitfalls and take steps to optimize insulin glargine therapy, as recommended by the American Academy of Family Physicians 1, 3, 4
• Clinical signals for potential overbasalization, such as elevated bedtime-to-morning glucose differential, high postprandial-to-preprandial glucose differential, hypoglycemia, and high glucose variability, may require split dosing and dose adjustment using an evidence-based titration algorithm, reducing dose by 10-20% for hypoglycemia without clear cause 3, 4